Halozyme Therapeutics Investor Relations Material
Latest events
Q1 2025
Halozyme Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Halozyme Therapeutics Inc
Access all reports
Halozyme Therapeutics Inc is a biotechnology company that develops and licenses drug delivery technology and oncology therapeutics. Its ENHANZE drug delivery platform is used to facilitate the subcutaneous administration of biologics. The company also has proprietary oncology assets under development. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Halozyme Therapeutics Inc
Guidance
Halozyme Therapeutics Inc
Q1 2025
Halozyme Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
HALO
Country
🇺🇸 United States